drugset / Trial / NCT03577509

Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China

NCT03577509

Phase 1 Completed 30 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
SequentialOpen-labelTreatment

Summary

The purpose of this trial is to evaluate the pharmacokinetics of single intravenous of Amphotericin B Colloidal Dispersion(ABCD)in Chinese healthy subjects.

Timeline

Start
2018-07-02
Primary completion
2018-09-14
Completion
2018-09-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 0.5 mg/kg Intravenous
Subject Amphotericin B Unknown 1 mg/kg Intravenous
Subject Amphotericin B Unknown 1.5 mg/kg Intravenous